13F
← All fund report cards

Copeland Capital Management, LLC

13F equity value
$4.5B
Positions
257
Top 10 concentration
20.1%
Quarters / total new picks
32 / 447
13F equity value over time
$0M$3B$6B2017201820192020202120222023202420252026

"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.

Not significant Verdict

13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.

We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 32 quarters, returned +3.8% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 62.5% of quarters (excess t = 0.91, not statistically significant). Its filings tell you what it bought — not what you should buy.

Avg 2Q excess
+1.7%
t-stat
0.91
Quarterly win rate
63%
Annualized excess
+4.9%
$1 → follow vs universe
$2.97 vs $2.09
Cumulative return: $1 invested in new picks vs universe
1.00 20180331: universe 1.04120180630: universe 0.95920180930: universe 1.00320181231: universe 0.99220190331: universe 0.97520190630: universe 1.04820190930: universe 1.12720191231: universe 0.90920200331: universe 1.09620200630: universe 1.21120200930: universe 1.48520201231: universe 1.55320210331: universe 1.56620210630: universe 1.69220210930: universe 1.51920211231: universe 1.29220220331: universe 1.38720220630: universe 1.28520220930: universe 1.38120221231: universe 1.28220230331: universe 1.35120230630: universe 1.30320230930: universe 1.47920231231: universe 1.54520240331: universe 1.58020240630: universe 1.72320240930: universe 1.70820241231: universe 1.59420250331: universe 1.73820250630: universe 1.79320250930: universe 2.01620251231: universe 2.085 20180331: follow 1.06320180630: follow 0.92720180930: follow 1.10920181231: follow 1.13720190331: follow 1.16620190630: follow 1.25620190930: follow 1.31820191231: follow 1.11320200331: follow 1.27420200630: follow 1.33120200930: follow 1.46720201231: follow 1.60220210331: follow 1.70320210630: follow 1.93720210930: follow 1.92820211231: follow 1.79020220331: follow 1.93620220630: follow 1.72220220930: follow 1.88920221231: follow 1.73720230331: follow 1.98820230630: follow 1.92620230930: follow 2.15620231231: follow 2.11820240331: follow 1.99720240630: follow 2.34720240930: follow 2.34120241231: follow 2.41120250331: follow 2.52920250630: follow 2.46020250930: follow 2.80720251231: follow 2.966 0.84 2.02 3.20 20182019202020212022202320242025 Follow Universe

Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)

Listed as facts. See the verdict above before treating this as signal.

Top 20 holdings of 257 · 2026 Q1

Ticker Value Weight QoQ
ENSG $120M
2.7%
TRIM
PSMT $96M
2.1%
TRIM
LMAT $95M
2.1%
TRIM
LFUS $89M
2.0%
TRIM
WCC $88M
2.0%
TRIM
EHC $86M
1.9%
ADD
YOU $85M
1.9%
TRIM
MTDR $82M
1.8%
TRIM
VMI $82M
1.8%
TRIM
NSSC $79M
1.8%
ADD
KLIC $76M
1.7%
TRIM
HXL $75M
1.7%
TRIM
TNL $70M
1.6%
TRIM
PRDO $69M
1.5%
ADD
HOMB $69M
1.5%
TRIM
CGNX $68M
1.5%
HOLD
POWI $68M
1.5%
ADD
AAON $65M
1.5%
HOLD
BC $65M
1.4%
HOLD
CTRE $65M
1.4%
TRIM

QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.

Listed as facts. See the verdict above before treating this as signal.

New positions in 2026 Q1

Method & Limitations

Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.